Statements (18)
Predicate | Object |
---|---|
gptkbp:instanceOf |
antipsychotic medication
|
gptkbp:alsoKnownAs |
loxapine succinate
|
gptkbp:approvedBy |
1975
|
gptkbp:ATCCode |
N05AA09
|
gptkbp:developedBy |
Aventis Pharmaceuticals
|
gptkbp:drugClass |
typical antipsychotic
|
https://www.w3.org/2000/01/rdf-schema#label |
DMS-25
|
gptkbp:legalStatus |
prescription only
|
gptkbp:mechanismOfAction |
dopamine receptor antagonist
|
gptkbp:routeOfAdministration |
oral
intramuscular injection |
gptkbp:sideEffect |
weight gain
sedation dry mouth extrapyramidal symptoms |
gptkbp:usedFor |
treatment of schizophrenia
|
gptkbp:bfsParent |
gptkb:USS_Fitch_(DD-462)
|
gptkbp:bfsLayer |
6
|